Pharmacists in Butler, Pennsylvania


77 Pharmacists found in Butler
female pharmacist

Skyler Paige Kokocinski, PHARMD


Pharmacist
353 N Duffy Rd, Butler, PA 16001
412-999-9612    

female pharmacist

Stephanie Renee Siegel, RPH


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
353 N Duffy Rd, Butler, PA 16001
878-271-6680    

female pharmacist

Susan D Tirch, PHARMD


Pharmacist
200 Moraine Pointe Plz, Butler, PA 16001
724-282-2120    



female pharmacist

Mrs. Susan Hagan


Pharmacist
280 New Castle Rd, Butler, PA 16001
724-282-9414    

female pharmacist

Mrs. Susan L Mossgrove, RPH


Pharmacist
325 New Castle Rd, Butler, PA 16001
724-287-4781     724-477-5036

female pharmacist

Taylor Elizabeth Dzikowski, PHARMD


Pharmacist
1521 N Main Street Ext, Butler, PA 16001
724-282-9160     724-282-1648

male pharmacist

Mr. Terry Rex Wingfield, RPH


Pharmacist
325 New Castle Rd, Butler, PA 16001
724-285-2505    

male pharmacist

Thomas David Willoughby, PHARM.D.


Pharmacist
1 Hospital Way, Butler, PA 16001
724-284-4552    

female pharmacist

Ms. Tiffany Jean Kimmerle, PHARMD


Pharmacist
325 New Castle Rd, Butler, PA 16001
180-036-2826    

male pharmacist

Troy Matthew Reinsel, PHARMD


Pharmacist
140 Shanor Hts, Butler, PA 16001
724-504-4506    

female pharmacist

Victoria Pattison


Pharmacist
325 New Castle Rd, Butler, PA 16001
800-362-8262    

male pharmacist

Mr. William John Dalmagro, R.PH.


Pharmacist
325 New Castle Rd, Butler, PA 16001
724-285-2761     724-285-2700

male pharmacist

Zachary Michel


Pharmacist
200 Butler Cmns, Butler, PA 16001
724-283-7269    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.